On March 23–24, 2026, the VaMPiRE project convened its annual General Assembly in Barcelona, bringing together consortium partners to review progress, share insights, and align on next steps.
The meeting commenced on the afternoon of March 23 with opening remarks from Dr. Robert Jenkins, CEO of Linkcare. In his address, he welcomed three new beneficiaries to the consortium: LEITAT Technology Center, Sapienza University of Rome, and Universidad de Oviedo, marking an important expansion of the project’s collaborative network.
Updates on project management and coordination were subsequently presented by Nunzia Tramontano of Casa di Cura IGEA and Eduard Boada, COO of Linkcare. This was followed by a comprehensive progress report on the clinical trial, delivered by Dr. Elda Judica (Casa di Cura IGEA) and Josep Benavent, Project Manager at Linkcare.
A key highlight of the first day was the presentation by Almawave, the project’s analytical partner, which is responsible for AI-driven processing of clinical data. Together with Pedro Sánchez, CTO of Linkcare, the team shared the latest developments in retrospective study clusters and clinical study analysis.
The day concluded with a networking dinner at La Dolça Hermínia, where partners had the opportunity to connect and exchange ideas in a relaxed and convivial atmosphere.
Proceedings resumed on the morning of March 24 with a presentation by Dr. Marco Feligioni, who outlined recent advances in scientific research. Linkcare and LEITAT then provided an update on the design and development of the in vitro diagnostic (IVD) component, a key element of the project.
The second day also featured a series of research presentations from consortium partners. Contributions included updates from Dr. Tiago Oteiro (University Medical Center Göttingen), Dr. Mariarosaria Incoronato (SYNLAB), Dr. Salvador Ventura (Universitat Autònoma de Barcelona), Dr. Chiara Guerrera (INSERM), and Dr. Maria Teresa Fernández (Universidad de Oviedo), each highlighting progress and future directions within their respective laboratories.
The General Assembly concluded with final updates on coordination, dissemination, and communication activities, presented by Dr. Robert Jenkins and Effie Wu of Linkcare.
Overall, the 2026 VaMPiRE General Assembly underscored the project’s steady progress and reinforced collaboration among its growing network of partners, setting a strong foundation for the next phase of development.
